Stocktoria

Rein Therapeutics, Inc. RNTX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2017-06-29

Rein Therapeutics, Inc. statistics & valuation

Market cap$83.1M
P / B4.9×
Return on capital-281.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-47.30% -161.00% -183.00% -224.70% -59.60% -146.70% -16.00% -115.60% -294.80% 2016201720182019202020212022202320242025
Shares outstanding
432413 14.7M 14.7M 27.8M 43.8M 4.5M 4.5M 4.9M 21.7M 27.6M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-82.30% -42.90% -104.10% -110.90% -167.20% -54.00% -124.20% -14.80% -101.10% -206.40% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$5.89 -$6.02 -$3.42 -$3.51 -$1.96 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-206.4%-101.1%-14.8%-124.2%-54.0%-167.2%-110.9%-104.1%-42.9%-82.3%
Return on equity-294.8%-115.6%-16.0%-146.7%-59.6%-224.7%-183.0%-161.0%-47.3%16.2%
Current ratio0.702.384.176.4610.694.123.354.0510.605.18

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.